Narrow search
Showing 1 - 10 of 10,992
Cover Image
Chapter Twelve. Markets for Pharmaceutical Products
Scott Morton, Fiona; Kyle, Margaret - In: Handbook of health economics : volume 2, (pp. 763-823). 2011
This chapter describes the market for pharmaceuticals, which exceeded $500 million in sales in 2010. The industry is …
Persistent link: https://www.econbiz.de/10014025576
Cover Image
Ask your doctor or pharmacist! : on the effect of self-dispensing physicians on pharmaceutical coverage
Bannert, Matthias; Iselin, David - 2015
In most developed countries drugs are dispensed to patients through physicians and pharmacists. This paper studies the effects of allowing doctors to directly dispense drugs to patients (self-dispensation) on pharmaceutical coverage. We use a Swiss dataset in our empirical analysis because...
Persistent link: https://www.econbiz.de/10011280788
Cover Image
Shortages of medicines in OECD countries
Chapman, Suzannah - 2022
Even in wealthy economies, access to medicines is increasingly affected by medicine shortages – an issue exacerbated with the onset of the COVID-19 pandemic. The aim of this paper was to examine the extent and nature of medicine shortages in OECD countries (pre-COVID-19) and explore the...
Persistent link: https://www.econbiz.de/10013174584
Cover Image
Pharmaceutical Pricing and Reimbursement Policies in Slovakia
Kaló, Zoltán - 2008
income going to pharmaceuticals is exceeded only in Hungary. Although its relatively low national income is a partial … social insurance scheme, the cost-effectiveness of new pharmaceuticals is not assessed. On the other hand, certain policy …
Persistent link: https://www.econbiz.de/10012444689
Cover Image
Pharmaceutical Pricing and Reimbursement Policies in Switzerland
Paris, Valérie - 2007
This paper examines aspects of the policy environment and market characteristics of the Swiss pharmaceutical sector, and assesses the degree to which Switzerland has achieved certain policy goals. In Switzerland, pharmaceutical spending has not been growing faster than health expenditure as a...
Persistent link: https://www.econbiz.de/10012445049
Cover Image
Pharmaceutical Pricing and Reimbursement Policies in Canada
Paris, Valérie - 2006
This paper describes and assesses pharmaceutical pricing and reimbursement policies in Canada, considering them in the context of the broader policy and market environment in which they operate, and investigating their role in contributing to Canada’s achievements in meeting a range of...
Persistent link: https://www.econbiz.de/10012445168
Cover Image
Pharmaceutical Use and Expenditure for Cardiovascular Disease and Stroke : A Study of 12 OECD Countries
Dickson, Michael - 2003
This study presents the results of a joint analysis of patterns of consumption, expenditure, and unit expenditure for a core set of drugs aimed at preventing and treating cardiovascular disease. The current study examines the relationships among three pharmaceutical variables (expenditure,...
Persistent link: https://www.econbiz.de/10012445354
Cover Image
Pharmaceutical Pricing and Reimbursement Policies in Mexico
Moi͏̈se, Pierre - 2007
price regulation. It notes that retail prices for pharmaceuticals are relatively high, although proximity to the United … question the sustainability of financing pharmaceuticals in Mexico. It also contributes to greater inequality, although a new … unintended side-effect of the loss of low cost, non-bioequivalent drugs may be higher average prices for pharmaceuticals. …
Persistent link: https://www.econbiz.de/10012446729
Cover Image
Pharmaceutical Pricing and Reimbursement Policies in Sweden
Moi͏̈se, Pierre - 2007
national income to pharmaceuticals. What limited evidence exists tends to suggest that relatively low pharmaceutical … to low mark-ups in the distribution chain and no VAT for prescribed medicines, Sweden's public prices for pharmaceuticals … reimbursement status of new pharmaceuticals and mandatory substitution of the lowest-cost generic alternative. The use of cost …
Persistent link: https://www.econbiz.de/10012447076
Cover Image
Improving the Czech health care system
Fall, Falilou; Glocker, Daniela - 2018
The Czech health care system is doing well in terms of health outcomes compared to other Central East European economies that inherited similar health systems after the transition and has been converging to OECD averages. However, benchmarking the Czech health system to countries with comparable...
Persistent link: https://www.econbiz.de/10011995780